Skip to main content
Clinical Trials/NL-OMON27534
NL-OMON27534
Recruiting
Not Applicable

Genetic variations as predictors of outcome and toxicity in non-small-cell lung cancer patients undergoing chemoradiation or chemotherapy with platinum agents.

St Antonius Ziekenhuis0 sites350 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
SCLCNiet-kleincellig longcarcinoomToxicityToxiciteitPlatinum agentsPlatinumhoudende chemotherapie
Sponsor
St Antonius Ziekenhuis
Enrollment
350
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
St Antonius Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with NSCLC (stage II\-IV).
  • \- Age \>18 year.

Exclusion Criteria

  • \- Unable to give informed consent.
  • \- Patients with cognitive impairment or those who are not able to read or write Dutch (because of difficulties in completing questionnaires).

Outcomes

Primary Outcomes

Not specified

Similar Trials